Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
- Supplementary File 1:
PDF-Document (PDF, 224 KiB)
Blanch-Lombarte, O.; Gálvez, C.; Revollo, B.; Jiménez-Moyano, E.; Llibre, J.M.; Manzano, J.L.; Boada, A.; Dalmau, J.; E. Speiser, D.; Clotet, B.; G. Prado, J.; Martinez-Picado, J. Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab. J. Clin. Med. 2019, 8, 2089. https://doi.org/10.3390/jcm8122089
Blanch-Lombarte O, Gálvez C, Revollo B, Jiménez-Moyano E, Llibre JM, Manzano JL, Boada A, Dalmau J, E. Speiser D, Clotet B, G. Prado J, Martinez-Picado J. Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab. Journal of Clinical Medicine. 2019; 8(12):2089. https://doi.org/10.3390/jcm8122089
Chicago/Turabian StyleBlanch-Lombarte, Oscar; Gálvez, Cristina; Revollo, Boris; Jiménez-Moyano, Esther; Llibre, Josep M.; Manzano, José L.; Boada, Aram; Dalmau, Judith; E. Speiser, Daniel; Clotet, Bonaventura; G. Prado, Julia; Martinez-Picado, Javier. 2019. "Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab" J. Clin. Med. 8, no. 12: 2089. https://doi.org/10.3390/jcm8122089